Abrdn Life Sciences Investors
HQL
Last
$18.15
Day
+4.1%
1y
+8.3%
5y
-12.4%
52w
-23.1%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
18.64
EMA 50
19.32
EMA 200
18.30
20d high
-13.7%
5y high
-23.1%
5y range
57th
Positions held
Your positionsHQL isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-16
Hold
avoid
Signal
Strong Sell
Target
$18.46
Stop
$16.57
Stop distance
8.7%
Target vs last
+1.7%
Fundamentals
| Market cap | — | Enterprise value | $529.16M | Trailing P/E | 2.63 | Forward P/E | — |
| PEG | — | Price / book | 0.95 | Beta | 0.73 | Dividend yield | 12.85% |
| Revenue growth | -60.8% | Earnings growth | — | Gross margin | 100.0% | Operating margin | -5.2% |
| Profit margin | 178.6% | ROE | 41.4% | ROA | -0.6% | Debt / equity | — |
| Current ratio | 1.61 | Free cash flow | -$4.35M | Analyst recommendation | none | Mean target | — |
| 52w high | $22.67 | 52w low | $15.66 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $86.4M | $86.7M | $23.5M | -$103M |
| Op margin | — | — | — | — |
| Net income | $85.6M | $85.3M | $22.4M | -$105M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsHQL · daily-12.8% over 13 sessions
Close EMA21 EMA50 EMA200